US Patent Issued to TAURUS BIOSCIENCES on April 21 for "Humanized antibodies with ultralong complementary determining regions" (California Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,937, issued on April 21, was assigned to TAURUS BIOSCIENCES LLC (Emeryville, Calif.).

"Humanized antibodies with ultralong complementary determining regions" was invented by Omar Bazirgan (Emeryville, Calif.) and Miguel De Los Rios (Emeryville, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides humanized antibodies, including antibodies comprising an ultralong CDR3 and uses thereof."

The patent was filed on Nov. 9, 2022, under Application No. 18/054,045.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml...